Switzerland · 
What does Endeavour Vision invest in?
Endeavour Vision invests most often at Series C and Series B (58% of the rounds on record), in sectors such as Healthcare, Medical Devices and Digital Health.
Endeavour Vision highlights
- 01
35 rounds on record
- 02
Mostly Series C and Series B: 58% of its rounds
- 03
Sole investor in 7 rounds, median undisclosed
- 04
5 exits from the portfolio
What they do
Endeavour Vision is an investment firm focused on transformative healthcare technologies.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- Series ASeries B
- Sectors
- HealthcareMedical DevicesDigital Health
- Based in
- Geneva, Switzerland
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first35 appearances
- 2019
1 round
- Jan
- 2015
4 rounds
- Sept
- Aug
- Jul
- May
- 2014
2 rounds
- Jul
- Mar
- 2013
2 rounds
- Dec
- Jul
- 2012
4 rounds
- Oct
- Sept
- May
- Feb
- 2011
5 rounds
- Jul
- Apr
- Feb
- Jan
- Jan
- 2010
6 rounds
- Oct
- Sept
- Sept
- Jun
- Jan
- Jan
- 2009
2 rounds
- Dec
- Jun
- 2008
2 rounds
- Sept
- Mar
- 2007
3 rounds
- Sept
- Aug
- Aug
- 2006
2 rounds
- May
- Mar
- 2005
1 round
- Apr
- 2004
1 round
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 12 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$617Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Endeavour Vision SA
- SEC number
- CRD 315299
What they claim to have backed
From their own portfolio page (on their website)
0 of 1 we have independently watched raise
Knight Chung
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed5 in all
OncoEthixBought by Merck & Co.UndisclosedDec 2014
RetailoBought by BlackHawk NetworkUndisclosedDec 2013
Nfocus NeuromedicalBought by Covidien$72MFeb 2013
An exit counts when it came after the firm's first round in the company. From historical deal records.